The average Chinese person now accounts for more carbon emissions annually than the average European
The latest Ferrari glitch may or may not be a flaw, depending on how often you plan to use your $234,000 sports car in kidnappings
NASA's decision to hire both Boeing and SpaceX to design and build new space shuttles illustrates a debate in government contracting as to how many suppliers is best
The photo agency is increasingly making its work available to customers without a licensing fee, with the plan to develop a business model at some point in the future
The popular premixed funds are supposed to get more conservative as retirement gets closer. What “conservative” means is open to interpretation
Airbus has reduced the width of a bathroom on the new A320s to restore space in the food-preparation area
Has anyone enjoyed being a CEO more than Oracle's sort-of outgoing Larry Ellison?
Business students at Wharton reveled in a ritual gathering of MBAs where people leave their personal brand at the door
A report finds high default rates on franchise loans
Kathy Callender, 67
After 12 years in business, PharmaJet may finally be able to sell its first product: a simple, needle-free injection device with a disposable syringe designed for use in third-world countries that can help prevent injury and the spread of disease. The company just received clearance from the Food & Drug Administration to use the tool for vaccines and injectable medicines. The 25-person company has not recorded any revenues to date, but plans to start selling its devices this year. So far, it has been developing the product with help from angel investors. "I want to make a difference in global world health," says Callender, a 35-year veteran of the health-care industry. "Before starting the firm, my husband and I would do medical mission work in the developing world, and it really just showed us how much need there is out there. I want to get needles out of the garbage and prevent injury to workers and patients."